Abstract: The present invention relates to a method and materials for producing glucosamine by fermentation of a genetically modified microorganism. Included in the present invention are genetically modified microorganisms useful in the present method for producing glucsamine, as well as recombinant nucleic acid molecules and the proteins produces by such recombinant nucleic acid molecules.
Type:
Application
Filed:
October 5, 2005
Publication date:
May 4, 2006
Applicant:
Arkion Life Sciences LLC d/b/a Bio-Technical Resources
Inventors:
Alan Berry, Richard Burlingame, James Millis
Abstract: A food product and method for treating and preventing diarrhea in a subject animal suffering from or susceptible to diarrhea. The method comprises administering an egg product to the subject animal wherein the egg product is obtained from a hyperimmunized avian.
Type:
Grant
Filed:
January 22, 2002
Date of Patent:
October 12, 2004
Assignee:
Arkion Life Sciences
Inventors:
Hellen Chaya Greenblatt, Orn Adalsteinsson, David A. Brodie, Henry Jacoby
Abstract: The present invention provides an isolated linoleate isomerase and its nucleic acid and amino acid sequence. The present invention also provides a method for producing CLA from an oil using an immobilized bacterial cell or an isolated linoleate isomerase.
Type:
Grant
Filed:
December 23, 1998
Date of Patent:
June 1, 2004
Assignee:
Arkion Life Sciences LLC
Inventors:
Reinhardt A. Rosson, Alan D. Grund, Ming-De Deng, Fernando Sanchez-Riera
Abstract: A composition, preferably used to reduce methane formation in a ruminant, wherein the composition is a combination of a polycyclic quinone compound and an ionophore compound.
Abstract: A method for supplementing new antibody or adding additional titer of an already present antibody into the circulating system in a newborn by feeding antibody to the newborn within the first few days of its life. The antibody is preferably obtained from the egg of an immunized mother and fed to the newborn within the first 24 hours of its life.
Type:
Grant
Filed:
June 27, 2002
Date of Patent:
May 4, 2004
Assignee:
Arkion Life Sciences LLC
Inventors:
Leslie A. Confer, Jeffrey G. Hunchar, Kevin C. Somerville
Abstract: The present invention provides an isolated (trans,cis)-10,12-linoleate isomerase and its nucleic acid and amino acid sequences. The present invention also provides a method for producing conjugated linoleic acid or conjugated linolenic acid (CLA), or derivatives thereof, from an oil using an immobilized cell and/or an isolated linoleate isomerase. The present invention also provides an isolated lipase-like protein and its nucleic acid and amino acid sequences. The present invention also provides an isolated acetyltransferase-like enzyme and its nucleic acid and amino acid sequences.
Type:
Grant
Filed:
April 28, 2000
Date of Patent:
March 16, 2004
Assignee:
Arkion Life Sciences LLC
Inventors:
Reinhardt A. Rosson, Ming-De Deng, Alan D. Grund
Abstract: The invention is directed to a composition and method for the treatment and prevention of inflammation and inflammatory related disorders. The composition is glucosamine in combination with an egg product. It is generally preferred that the egg product is obtained from an avian which has been hyperimmunized with an immungenic mixture and/or which contains an anti-inflammatory composition.
Type:
Grant
Filed:
September 7, 2000
Date of Patent:
March 16, 2004
Assignee:
Arkion Life Sciences LLC
Inventors:
Orn Adalsteinsson, Jeffrey G. Hunchar, Subramanian Iyer
Abstract: The present invention relates to a method and materials for producing glucosamine by fermentation of a genetically modified microorganism. Included in the present invention are genetically modified microorganisms useful in the present method for producing glucsamine, as well as recombinant nucleic acid molecules and the proteins produces by such recombinant nucleic acid molecules.
Type:
Application
Filed:
December 17, 2001
Publication date:
March 6, 2003
Applicant:
Arkion Life Sciences LLC
Inventors:
Alan Berry, Richard P. Burlingame, James R. Millis
Abstract: A product and method for reducing and preventing the ingestion of substrates by avians wherein the substrates are disposed within an avian house. The product is a bird repellent in combination with a substrate disposed within an avian house. As a result of the reduced ingestion of substrates such as litter, healthier avians are achieved.
Type:
Grant
Filed:
June 15, 1999
Date of Patent:
August 20, 2002
Assignee:
Arkion Life Sciences
Inventors:
Kenneth E. Ballinger, Jr., Craig W. Henry
Abstract: Disclosed is an isolated Cytokine Activating Factor (CAF) protein, an isolated nucleic acid molecule encoding a CAF protein, an antibody that selectively binds to a CAF protein, a composition comprising a Cytokine Activating Factor (CAF), and a method for modulating the immune system using the composition. Also disclosed is a method for treating cancer using such a composition.
Type:
Grant
Filed:
July 20, 2000
Date of Patent:
July 16, 2002
Assignee:
Arkion Life Sciences LLC
Inventors:
Subramanian Iyer, Tay N. Nguyen, Dauh-Rurng Wu, Ruye Xing
Abstract: The present invention relates to a method and materials for producing glucosamine by fermentation of a genetically modified microorganism. Included in the present invention are genetically modified microorganisms useful in the present method for producing glucsamine, as well as recombinant nucleic acid molecules and the proteins produces by such recombinant nucleic acid molecules.
Type:
Grant
Filed:
July 15, 1998
Date of Patent:
April 16, 2002
Assignee:
Arkion Life Sciences LLC
Inventors:
Alan Berry, Richard P. Burlingame, James R. Millis
Abstract: A method for deterring birds from perching, roosting or loafing on plant and structural surfaces by applying to the surfaces a non-toxic composition. The non-toxic composition is one that triggers a physiological aversion mechanism in birds by a visual cue and a post-ingestinal response.
Abstract: The invention is an acid-chitosan complex which is made up of chitosan, a sufficient amount of one or more acids, and an effective amount of water. This acid-chitosan is water-soluble in a dry form. A further aspect of this invention is various methods for producing such a water-soluble acid-chitosan complex and methods for using this acid-chitosan complex, particularly for reducing fat absorption in an animal.
Type:
Grant
Filed:
February 25, 2000
Date of Patent:
December 4, 2001
Assignee:
Arkion Life Sciences
Inventors:
J. David Angerer, Donald M. Cyron, Subramanian Iyer, Thomas A. Jerrell
Abstract: A method for reducing the level of hydrogen sulfide in water containing sulfur-reducing bacteria and hydrogen sulfide-metabolizing bacteria by addition of an aqueous solution of metallic nitrogen oxides and small particles of water-insoluble polycyclic quinones.
Type:
Grant
Filed:
January 12, 1999
Date of Patent:
October 30, 2001
Assignee:
Arkion Life Sciences
Inventors:
Kenneth E. Ballinger, Jr., Edward D. Burger, Robert F. Knauer